ANTIPSEUDOMONAL ANTIBIOTICS USE AND HOSPITALIZATIONS FOR PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS TREATED WITH TOBRAMYCIN INHALATION POWDER, TOBRAMYCIN INHALATION SOLUTION OR AZTREONAM FOR INHALATION SOLUTION: A RETROSPECTIVE STUDY OF US HEALTH CLAIMS DATABASES

Osman K.; Dhariwal M.; Conti V; McSharry M.; Zhou W.; Chandra R.

首页> 外文期刊>Pediatric Pulmonology >ANTIPSEUDOMONAL ANTIBIOTICS USE AND HOSPITALIZATIONS FOR PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS TREATED WITH TOBRAMYCIN INHALATION POWDER, TOBRAMYCIN INHALATION SOLUTION OR AZTREONAM FOR INHALATION SOLUTION: A RETROSPECTIVE STUDY OF US HEALTH CLAIMS DATABASES

【24h】

ANTIPSEUDOMONAL ANTIBIOTICS USE AND HOSPITALIZATIONS FOR PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS TREATED WITH TOBRAMYCIN INHALATION POWDER, TOBRAMYCIN INHALATION SOLUTION OR AZTREONAM FOR INHALATION SOLUTION: A RETROSPECTIVE STUDY OF US HEALTH CLAIMS DATABASES

机译：抗癫痫抗生素使用和住院治疗膀胱纤维化患者的膀胱纤维化患者，用烟霉素吸入粉末，Tobramycin吸入溶液或吸入解决方案的Aztroonam：对美国健康声称数据库的回顾性研究

获取原文

获取原文并翻译 | 示例

掌桥外文数据库（机构版） >>

开具论文收录证明 >>

文献代查 >>

页面导航

著录项
相似文献
相关主题

著录项

来源
《Pediatric Pulmonology》 |2018年第2期|共1页
作者
Osman K.; Dhariwal M.; Conti V; McSharry M.; Zhou W.; Chandra R.;
展开▼
作者单位

Novartis Pharmaceut E Hanover NJ USA;

Novartis Ireland Ltd Dublin Ireland;

Novartis Ireland Ltd Dublin Ireland;

Novartis Ireland Ltd Dublin Ireland;

Novartis Pharmaceut E Hanover NJ USA;

Novartis Pharmaceut E Hanover NJ USA;

展开▼
收录信息
原文格式 PDF
正文语种 eng
中图分类儿科学;
关键词

相似文献

外文文献
中文文献
专利

1. ANTIPSEUDOMONAL ANTIBIOTICS USE AND HOSPITALIZATIONS FOR PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS TREATED WITH TOBRAMYCIN INHALATION POWDER, TOBRAMYCIN INHALATION SOLUTION OR AZTREONAM FOR INHALATION SOLUTION: A RETROSPECTIVE STUDY OF US HEALTH CLAIMS DATABASES [J] . Osman K., Dhariwal M., Conti V, Pediatric Pulmonology . 2018,第Suppla2期

机译：抗癫痫抗生素使用和住院治疗膀胱纤维化患者的膀胱纤维化患者，用烟霉素吸入粉末，Tobramycin吸入溶液或吸入解决方案的Aztroonam：对美国健康声称数据库的回顾性研究
2. COST-EFFECTIVENESS OF LEVOFLOXACIN INHALATION SOLUTION VS. AZTREONAM INHALATION SOLUTION AND TOBRAMYCIN DRY POWDER FOR INHALATION IN CYSTIC FIBROSIS PATIENTS IN SWEDEN [J] . Medic G., Franck-Larsson K., Wille M., Value in health: the journal of the International Society for Pharmacoeconomics and Outcomes Research . 2016,第7期

机译：左氧氟沙星吸入溶液VS.的成本效益瑞典囊性纤维化患者吸入氨氮酮吸入溶液和妥布霉素干粉吸入剂
3. AZTREONAM FOR INHALATION SOLUTION (AZLI) AND TOBRAMYCIN INHALATION SOLUTION (TIS) CONTINUOUS ALTERNATING THERAPY (CAT) FOR CYSTIC FIBROSIS (CF) PATIENTS WITH CHRONIC PSEUDOMONAS AERUGINOSA (PA) INFECTION: A RANDOMIZED, DOUBLE-BLIND, PLACEBO-CONTROLLED TRIAL [J] . Flume P. A., Clancy J. P., Retsch-Bogart G. Z., Pediatric Pulmonology . 2015,第Suppla41期

机译：慢性肺炎性铜绿假单胞菌感染的囊性纤维化（CF）病人的氨氮卓南吸入溶液（AZLI）和妥布霉素吸入溶液（TIS）连续交替治疗（CAT）：随机对照
4. Inhalable Dry Powder Microparticles for Delivery of Bacteriophages to Treat Cystic Fibrosis Associated Bacterial Lung Infections [C] . Rachit Agarwal, Christopher Johnson, Andres J Garcia Society for Biomaterials annual meeting and exposition . 2015

机译：吸入性干粉微粒用于递送噬菌体以治疗囊性纤维化相关的细菌性肺部感染
5. Economic evaluation of treating chronic obstructive pulmonary disease: The effects of early initiation of inhaled corticosteroids on exacerbation risks, utilization and costs. [D] . Akazawa, Manabu. 2007

机译：治疗慢性阻塞性肺疾病的经济评估：早期吸入皮质类固醇激素对恶化风险，利用和成本的影响。
6. Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data [O] . Kamal Hamed, Valentino Conti, Hengfeng Tian, 2017

机译：囊性纤维化患者对妥布霉素吸入粉末与吸入溶液的依从性：美国保险理赔数据分析
7. Adherence to tobramycin inhaled powder vs inhaled solution in patients with cystic fibrosis: analysis of US insurance claims data [O] . Kamal Hamed, Valentino Conti, Hengfeng Tian, 2017

机译：腺瘤吸入粉末对囊性纤维化患者的吸入溶液：美国保险声称数据分析

ANTIPSEUDOMONAL ANTIBIOTICS USE AND HOSPITALIZATIONS FOR PULMONARY EXACERBATIONS IN CYSTIC FIBROSIS PATIENTS TREATED WITH TOBRAMYCIN INHALATION POWDER, TOBRAMYCIN INHALATION SOLUTION OR AZTREONAM FOR INHALATION SOLUTION: A RETROSPECTIVE STUDY OF US HEALTH CLAIMS DATABASES

著录项

相似文献

相关主题

期刊订阅